CompuGroup Medical SE & Co. KGaA (VIE:COP2)
Austria · Delayed Price · Currency is EUR 26.78
+0.16 (0.60%)
At close: Feb 2, 2026
VIE:COP2 Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 18.25 | 34.6 | 45.92 | 73.41 | 68.97 | 73.19 |
Depreciation & Amortization | 72.77 | 73.73 | 71.04 | 78.93 | 75.83 | 55.59 |
Other Amortization | 36.05 | 36.05 | 33.3 | 33.05 | 28.73 | 20.12 |
Loss (Gain) From Sale of Assets | -1.06 | -1.16 | -1.04 | -0.16 | -1.69 | -0.14 |
Asset Writedown & Restructuring Costs | 1.87 | 1.87 | 11.45 | 0.34 | 6.15 | - |
Other Operating Activities | 4.21 | -32.26 | 27.94 | 2.63 | -23.74 | 13.28 |
Change in Accounts Receivable | -14.19 | 9.45 | 11.12 | -28.76 | -7.7 | -34.82 |
Change in Inventory | 2.79 | 4.21 | 10.58 | -8.79 | -2.28 | 9.49 |
Change in Accounts Payable | 18.26 | -0.55 | -21.08 | 15.57 | 23.91 | 11.26 |
Change in Unearned Revenue | 9.48 | -8.02 | -14.74 | -10.38 | 6.65 | -3.95 |
Change in Income Taxes | 7.97 | 9.04 | 10.84 | -17.82 | -14.01 | 3.11 |
Change in Other Net Operating Assets | 8.55 | 1.91 | -5.82 | 7.01 | 4.44 | 2.79 |
Operating Cash Flow | 164.95 | 128.88 | 179.53 | 145.03 | 165.27 | 149.93 |
Operating Cash Flow Growth | 19.16% | -28.21% | 23.79% | -12.25% | 10.23% | 35.69% |
Capital Expenditures | -22.15 | -24.81 | -18.97 | -25.85 | -27.05 | -17.68 |
Sale of Property, Plant & Equipment | 0.26 | 0.43 | 1.33 | 0.35 | 7.28 | 0.66 |
Cash Acquisitions | -7.88 | -47.58 | -50.24 | -64.77 | -94.16 | -400.24 |
Divestitures | 0.84 | 5.1 | - | 0.04 | 0.4 | 0.22 |
Sale (Purchase) of Intangibles | -38.04 | -38.11 | -48.88 | -50.56 | -44.39 | -38.05 |
Investment in Securities | - | -0.31 | -7.56 | -4.63 | -6.05 | -2.03 |
Other Investing Activities | -8.27 | - | - | - | - | - |
Investing Cash Flow | -75.24 | -105.28 | -124.33 | -145.41 | -163.98 | -457.12 |
Long-Term Debt Issued | - | 115 | 480 | 340 | 265.08 | 489.05 |
Long-Term Debt Repaid | - | -27.09 | -530.03 | -320.94 | -112.29 | -464.2 |
Net Debt Issued (Repaid) | -56.99 | 87.91 | -50.03 | 19.06 | 152.8 | 24.85 |
Issuance of Common Stock | - | - | - | - | - | 337.99 |
Repurchase of Common Stock | - | -14.64 | - | -9.11 | -96.1 | - |
Common Dividends Paid | - | -51.74 | -26.12 | -26.12 | -26.37 | -24.21 |
Other Financing Activities | -2.84 | -2.72 | -4.54 | -0.19 | -0.18 | -0.56 |
Financing Cash Flow | -59.84 | 18.81 | -80.69 | -16.36 | 30.15 | 338.07 |
Foreign Exchange Rate Adjustments | -0.78 | 0.45 | -0.57 | -0.08 | -0.02 | -1.33 |
Net Cash Flow | 29.09 | 42.87 | -26.06 | -16.83 | 31.43 | 29.56 |
Free Cash Flow | 142.8 | 104.08 | 160.56 | 119.18 | 138.23 | 132.25 |
Free Cash Flow Growth | 24.28% | -35.18% | 34.72% | -13.78% | 4.52% | 38.03% |
Free Cash Flow Margin | 11.89% | 8.77% | 13.08% | 10.14% | 13.01% | 15.21% |
Free Cash Flow Per Share | 2.70 | 1.97 | 3.06 | 2.28 | 2.61 | 2.52 |
Cash Interest Paid | 32.5 | 32.83 | 26.71 | 6.16 | 4.18 | 5.41 |
Cash Income Tax Paid | 21.68 | 40.51 | 26.59 | 39.03 | 49.28 | 20.55 |
Levered Free Cash Flow | 91.44 | 63.83 | 114.65 | 66.62 | 119.45 | 107.75 |
Unlevered Free Cash Flow | 110.74 | 83.47 | 129.84 | 72.32 | 122.83 | 111.07 |
Change in Working Capital | 32.86 | 16.04 | -9.09 | -43.17 | 11.02 | -12.11 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.